Skip to content

13F-HR filed by Indaba Capital Management, L.P.

Indaba Capital Management, L.P. filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 12 holding rows worth $166,599,294.

Accession
0001011438-25-000318
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 12 entries on the cover page, a total value of $166,599,294 stated on the cover page (in dollars after the unit check, H1), rows summing to $166,599,294 with VALUE read as dollars as filed, 13F file number 028-16058. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BANDWIDTH INC05988JAD5NOTE 0.500% 4/040,250,000$32,481,750dollars as filedprincipal
SUMMIT HOTEL PPTYS866082AA8NOTE 1.500% 2/129,039,000$27,793,227dollars as filedprincipal
ON24 INC68339B104COM4,240,256$22,049,331dollars as filed
ACCELERATE DIAGNOSTICS INC00430HAC6NOTE 5.000%12/137,049,299$18,524,650dollars as filedprincipal
IRONWOOD PHARMACEUTICALS INC46333XAH1NOTE 1.500% 6/117,000,000$15,080,700dollars as filedprincipal
EQUITY COMMONWEALTH294628102COM SH BEN INT8,403,411$13,529,492dollars as filed
TRAVERE THERAPEUTICS INC761299AB2NOTE 2.500% 9/113,000,000$12,780,300dollars as filedprincipal
BLACKBAUD INC COM09227Q100Stock193,000$11,975,650dollars as filed
ESPERION THERAPEUTICS INC NEW COM29664W105Stock3,000,000$4,320,000dollars as filed
ATLANTA BRAVES HLDGS INC047726302COM SER C93,811$3,753,378dollars as filed
EMBECTA CORP29082K105COMMON STOCK221,938$2,829,710dollars as filed
ADVANTAGE SOLUTIONS INC.00791N102COM CL A980,865$1,481,106dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001011438-25-000318this filing2025-05-15acceptance time not in the bulk data set